Supplement NDI Notification Guidance Cruel To Firms On Animal Testing
This article was originally published in The Rose Sheet
CFSAN’s latest draft guidance for NDI notifications does little to address the supplement industry’s concerns, and the “worst” aspect is a recommendation to test ingredients on animals when historical use data is not available, says a New Hope Network analyst.
You may also be interested in...
CHPA and CRN look forward to working with FDA to develop a path for the identification of pre-DSHEA ingredients, but say the FDA’s revised draft guidance for new dietary ingredient notifications still hampers innovation.
Korean beauty brand-focused Memebox reaches more than 3.3m users with its direct-to-consumer platform, including rapidly growing segments in China and the US. The startup, which just received $66m in new venture funding, leverages social media and celebrity partnerships to drive engagement and sales, while speedily introducing branded product lines of its own.
Seven of 10 CBD-containing supplement products tested in a lab did not contain the levels of CBD advertised on the label, says hemp, CBD and natural health product information publisher Remedy Reviews. Most products also were found to contain heavy metals.